We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$419M
AUM Growth
-$93.5M
Cap. Flow
-$140M
Cap. Flow %
-33.49%
Top 10 Hldgs %
52.05%
Holding
63
New
14
Increased
15
Reduced
10
Closed
20

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$99.3M
2
UNH icon
UnitedHealth
UNH
+$17.6M
3
TMO icon
Thermo Fisher Scientific
TMO
+$8.23M
4
BDX icon
Becton Dickinson
BDX
+$6.29M
5
HCA icon
HCA Healthcare
HCA
+$6.11M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$13.5M
2
UHS icon
Universal Health Services
UHS
+$11.4M
3
ZBH icon
Zimmer Biomet
ZBH
+$9.65M
4
WAT icon
Waters Corp
WAT
+$7.83M
5
BIIB icon
Biogen
BIIB
+$6.92M

Sector Composition

Rank Sector Weight
1 Healthcare 68.68%
2 Energy 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
26
Centene
CNC
$33.1B
$6.23M 1.49%
100,000
-40,000
-29% -$2.67M
BDX icon
27
Becton Dickinson
BDX
$50B
$6.15M 1.47%
+25,625
New +$6.29M
BRKR icon
28
Bruker
BRKR
$9.03B
$5.86M 1.4%
75,000
-20,000
-21% -$1.66M
REGN icon
29
Regeneron Pharmaceuticals
REGN
$82.1B
$5.79M 1.38%
+160,000
New +$99.3M
MOH icon
30
Molina Healthcare
MOH
$10.8B
$5.43M 1.3%
20,000
-20,000
-50% -$5.28M
TMO icon
31
Thermo Fisher Scientific
TMO
$223B
$5.36M 1.28%
+15,000
New +$8.23M
BMRN icon
32
BioMarin Pharmaceuticals
BMRN
$13.6B
$5.02M 1.2%
65,000
+10,000
+18% +$789K
SYK icon
33
Stryker
SYK
$133B
$4.88M 1.17%
12,500
-12,500
-50% -$3.34M
HUM icon
34
Humana
HUM
$46.7B
$4.86M 1.16%
12,500
-12,500
-50% -$5.31M
HOLX
35
DELISTED
Hologic
HOLX
$4.43M 1.06%
60,000
+10,000
+20% +$750K
OPCH icon
36
Option Care Health
OPCH
$3.57B
$3.76M 0.9%
+155,000
New +$3.6M
CYH icon
37
Community Health Systems
CYH
$409M
$3.69M 0.88%
+315,000
New +$4.11M
MRVI icon
38
Maravai LifeSciences
MRVI
$863M
$3.68M 0.88%
+75,000
New +$3.66M
TECH icon
39
Bio-Techne
TECH
$11.3B
$3.63M 0.87%
+30,000
New +$3.65M
DGX icon
40
Quest Diagnostics
DGX
$26.3B
$3.63M 0.87%
+6,000
New +$878K
GRFS
41
Grifois
GRFS
$5.4B
$2.92M 0.7%
+200,000
New +$3.03M
LHCG
42
DELISTED
LHC Group LLC
LHCG
$2.35M 0.56%
+15,000
New +$2.82M
ACHC icon
43
Acadia Healthcare
ACHC
$2.95B
$1.21M 0.29%
+18,893
New +$1.19M
A icon
44
Agilent Technologies
A
$41.9B
– –
-30,000
Closed -$4.43M
ABBV icon
45
AbbVie
ABBV
$439B
– –
-20,000
Closed -$2.25M
ARGX icon
46
argenx
ARGX
$54.8B
– –
-6,000
Closed -$1.81M
BIIB icon
47
Biogen
BIIB
$30.9B
– –
-20,000
Closed -$6.92M
BMY icon
48
Bristol-Myers Squibb
BMY
$130B
– –
-85,000
Closed -$5.68M
CAH icon
49
Cardinal Health
CAH
$54.5B
– –
-65,000
Closed -$3.71M
ILMN icon
50
Illumina
ILMN
$29.1B
– –
-8,224
Closed -$3.79M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q3 2021 Portfolio in Review

As of Q3 2021, Sivik Global Healthcare held 63 positions worth $419M, down 18% from $512M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sivik Global Healthcare withdrew a net $140M in Q3 2021, closing 20 positions and reducing 10 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 55% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Regeneron Pharmaceuticals worth $5.79M.

  • Sivik Global Healthcare's largest Q3 2021 buy was Regeneron Pharmaceuticals: 160,000 shares worth $5.79M.
  • Sivik Global Healthcare added most to UnitedHealth in Q3 2021, an estimated $17.6M increase.
  • Sivik Global Healthcare's biggest Q3 2021 reduction was Humana, cutting an estimated $5.31M.
  • Sivik Global Healthcare fully exited State Street SPDR S&P Biotech ETF in Q3 2021, selling an estimated $13.5M.
  • Sivik Global Healthcare's ten largest holdings make up 52% of its $419M portfolio in Q3 2021.
  • Sivik Global Healthcare opened 14 new positions and closed 20 in Q3 2021.
  • Sivik Global Healthcare's portfolio value fell 18% quarter-over-quarter to $419M.

Based on Sivik Global Healthcare's 13F filing for Q3 2021, filed 12 Nov 2021.